Vertex, Inc. (VERX)

With strong upside potential, Vertex, Inc. (NASDAQ:VERX) ranks among the overlooked tech stocks to invest in now. A bullish new analyst call follows a first quarter that beat guidance and a strategic acquisition aimed at expanding the company’s global reach.

An announcement from Vertex Pharmaceuticals ( ($VRTX) ) is now available. On July 6, 2026, Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals via a ...

An announcement from Equinox Gold ( ($TSE:EQX) ) is now available. On July 6, 2026, Equinox Gold announced it had sold 8,713,000 common shares of Versamet Royalties...

And amid the rise in value, the stock has hit a new all-time high. Is it too late to buy shares of Vertex, or could there still be more gains ahead? Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the …

Crinetics Pharmaceuticals Inc. stocks have been trading up by 98.73 percent after promising clinical trial news fueled investor optimism. Key Takeaways Vertex will acquire Crinetics for $85 per share in cash, valuing CRNX around $10B, with closing targeted for Q3 2026, pending approvals.